Covered recipient · General Payments record
CHRISTINA STAGGS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,216.57
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $567.15 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $276.44 | 14 |
| Amgen Inc. | $91.43 | 1 |
| Exact Sciences Corporation | $44.61 | 2 |
| Astellas Pharma US Inc | $36.89 | 2 |
| Gilead Sciences, Inc. | $30.24 | 1 |
| GlaxoSmithKline, LLC. | $30.16 | 2 |
| Acerta Pharma LLC | $22.38 | 1 |
| Krystal Biotech Inc | $19.44 | 1 |
| Lilly USA, LLC | $15.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.21 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108242994 | CMS |
| ABBVIE INC. | $22.46 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108242996 | CMS |
| ABBVIE INC. | $8.91 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108242998 | CMS |
| ABBVIE INC. | $19.98 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243000 | CMS |
| ABBVIE INC. | $28.74 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243002 | CMS |
| ABBVIE INC. | $2.80 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243004 | CMS |
| ABBVIE INC. | $19.11 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243006 | CMS |
| ABBVIE INC. | $34.97 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243008 | CMS |
| ABBVIE INC. | $25.58 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243010 | CMS |
| ABBVIE INC. | $8.13 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243012 | CMS |
| ABBVIE INC. | $23.89 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243014 | CMS |
| ABBVIE INC. | $1.88 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243016 | CMS |
| ABBVIE INC. | $33.02 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243018 | CMS |
| ABBVIE INC. | $23.76 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108243020 | CMS |
| Amgen Inc. | $91.43 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117691430 | CMS |
| Astellas Pharma US Inc | $14.52 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139498188 | CMS |
| Astellas Pharma US Inc | $22.37 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139544775 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.38 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105335655 | CMS |
| Exact Sciences Corporation | $22.55 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114914961 | CMS |
| Exact Sciences Corporation | $22.06 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114914970 | CMS |
| Gilead Sciences, Inc. | $30.24 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133650822 | CMS |
| GlaxoSmithKline, LLC. | $14.45 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116719092 | CMS |
| GlaxoSmithKline, LLC. | $15.71 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116373009 | CMS |
| Krystal Biotech Inc | $19.44 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084811988 | CMS |
| Lilly USA, LLC | $15.56 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135586651 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.